Demonstrates a dual-action approach to eliminate MRSA biofilms and promote bone healing in periprosthetic joint infections, suggesting a novel treatment strategy.
Periprosthetic joint infection (PJI), sustained by antibiotic-tolerant biofilms, hinders infection control and impairs bone healing. To address this, we developed a dual-action strategy combining low-intensity pulsed ultrasound (LIPUS) with vancomycin-loaded microbubbles (MBs@V) designed to concurrently eliminate methicillin-resistant Staphylococcus aureus (MRSA) biofilms and enhance bone regeneration. In vitro, LIPUS activation of MBs@V generated cavitation that effectively disrupted mature biofilm architecture, significantly enhancing intrabiofilm vancomycin penetration and bactericidal efficacy. In vivo, using a rat model of PJI with infected titanium implants, the MBs@V + LIPUS therapy demonstrated synergistic effects: it markedly reduced bacterial burden and inflammation while remodeling the immune microenvironment through polarization of macrophages toward the reparative M2 phenotype and enhancing osteogenic activity. This immunomodulation and pro-osteogenic transition fostered a reparative environment, which simultaneously enhanced peri-implant bone mineralization and improved trabecular quality. Collectively, this integrated ultrasound-mediated approach provides a multifunctional platform for effective PJI management by synergistically targeting biofilm elimination and promoting bone regeneration.
No takes yet. Share an insight, caveat, or question.
Mu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: